Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells

NCT03634501 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT03634501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03634501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 26, 2018
Completion date
September 30, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer, lung cancer, ovarian cancer, pancreatic cancer